Is second-generation antipsychotic-induced hyperprolactinemia due to biologically active prolactin or to biologically inactive macroprolactin? Results from a prospective study.
Tschoner
Alexander
A
Engl
Julia
J
Rettenbacher
Maria A
MA
Kaser
Susanne
S
Ott
Helmut W
HW
Fleischhacker
W Wolfgang
WW
Patsch
Josef R
JR
Ebenbichler
Christoph F
CF
D000293:Adolescent; D000328:Adult; D000077582:Amisulpride; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D011388:Prolactin / Q000097:blood*; D011446:Prospective Studies; D012307:Risk Factors; D018967:Risperidone / Q000009:adverse effects / Q000627:therapeutic use; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy*; D013469:Sulpiride / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D055815:Young Adult
D014150:Antipsychotic Agents; C060678:prolactin, polymeric; D013469:Sulpiride; D000077582:Amisulpride; D011388:Prolactin; D018967:Risperidone